Moore Capital Management LP Takes $2.25 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Moore Capital Management LP bought a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 118,435 shares of the medical instruments supplier's stock, valued at approximately $2,248,000. Moore Capital Management LP owned about 0.06% of DENTSPLY SIRONA at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in XRAY. Treasurer of the State of North Carolina raised its position in shares of DENTSPLY SIRONA by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier's stock worth $1,686,000 after purchasing an additional 560 shares during the last quarter. UMB Bank n.a. raised its position in shares of DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after purchasing an additional 564 shares during the last quarter. Blue Trust Inc. raised its position in shares of DENTSPLY SIRONA by 10.9% in the 4th quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier's stock worth $137,000 after purchasing an additional 707 shares during the last quarter. Quarry LP increased its holdings in DENTSPLY SIRONA by 25.7% in the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after buying an additional 780 shares in the last quarter. Finally, Federated Hermes Inc. increased its holdings in DENTSPLY SIRONA by 0.5% in the 4th quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier's stock worth $3,213,000 after buying an additional 915 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ:XRAY traded up $0.20 during mid-day trading on Friday, reaching $16.70. 2,469,701 shares of the company traded hands, compared to its average volume of 2,968,916. The company's 50 day moving average price is $14.41 and its 200-day moving average price is $17.34. The firm has a market cap of $3.33 billion, a PE ratio of -8.07, a PEG ratio of 1.80 and a beta of 0.92. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. DENTSPLY SIRONA Inc. has a 52 week low of $12.16 and a 52 week high of $28.44.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. The company had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm's revenue was down 7.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.42 EPS. On average, equities analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were paid a $0.16 dividend. The ex-dividend date was Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 3.83%. DENTSPLY SIRONA's payout ratio is -14.10%.

Analyst Upgrades and Downgrades

XRAY has been the subject of several research analyst reports. Mizuho reduced their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a report on Thursday, March 13th. Wells Fargo & Company reduced their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a report on Friday, February 28th. StockNews.com upgraded DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Barrington Research lifted their price objective on DENTSPLY SIRONA from $20.00 to $21.00 and gave the stock an "outperform" rating in a report on Monday, May 12th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Eleven analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $20.36.

Insiders Place Their Bets

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the company's stock in a transaction on Monday, March 3rd. The stock was acquired at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now directly owns 81,971 shares of the company's stock, valued at $1,353,341.21. This trade represents a 22.66% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.50% of the stock is currently owned by corporate insiders.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.